Edoxaban versus warfarin on stroke risk in patients with atrial fibrillation: a territory-wide cohort study
Dicken Kong, Jiandong Zhou, Sharen Lee, Keith Sai Kit Leung, Tong Liu, Abhishek C Sawant, John Corbelli, Abraham KC Wai, Carlin Chang, View ORCID ProfileQingpeng Zhang, Gary Tse
doi: https://doi.org/10.1101/2021.01.04.21249209
Dicken Kong
1Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Li Ka Shing Institute of Health Sciences and Chinese University Research Institute, China
Jiandong Zhou
2School of Data Science, City University of Hong Kong, Hong Kong, China
MScSharen Lee
3Aston Medical School, Aston University, Birmingham, United Kingdom
Keith Sai Kit Leung
1Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Li Ka Shing Institute of Health Sciences and Chinese University Research Institute, China
3Aston Medical School, Aston University, Birmingham, United Kingdom
BSc MRSPHTong Liu
4Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
MD PhDAbhishek C Sawant
5Banner University Medical Center, Phoenix, Arizona, United States
MDJohn Corbelli
6Western New York Healthcare System, Buffalo VA Medical Center, Buffalo, New York, United States
MDAbraham KC Wai
7Emergency Medicine Unit, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
MBChB FRCEM FRCPCarlin Chang
8Division of Neurology, Department of Medicine, Queen Mary Hospital, Pokfulam, Hong Kong, China
MBChB MPhil MRCPQingpeng Zhang
1Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Li Ka Shing Institute of Health Sciences and Chinese University Research Institute, China
PhDGary Tse
4Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
PhD FESC FACC FRCPData Availability
Data available upon request.
Posted January 05, 2021.
Edoxaban versus warfarin on stroke risk in patients with atrial fibrillation: a territory-wide cohort study
Dicken Kong, Jiandong Zhou, Sharen Lee, Keith Sai Kit Leung, Tong Liu, Abhishek C Sawant, John Corbelli, Abraham KC Wai, Carlin Chang, Qingpeng Zhang, Gary Tse
medRxiv 2021.01.04.21249209; doi: https://doi.org/10.1101/2021.01.04.21249209
Edoxaban versus warfarin on stroke risk in patients with atrial fibrillation: a territory-wide cohort study
Dicken Kong, Jiandong Zhou, Sharen Lee, Keith Sai Kit Leung, Tong Liu, Abhishek C Sawant, John Corbelli, Abraham KC Wai, Carlin Chang, Qingpeng Zhang, Gary Tse
medRxiv 2021.01.04.21249209; doi: https://doi.org/10.1101/2021.01.04.21249209
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2694)
- Dermatology (229)
- Emergency Medicine (405)
- Epidemiology (12334)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4171)
- Geriatric Medicine (393)
- Health Economics (689)
- Health Informatics (2703)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3954)
- Nursing (214)
- Nutrition (587)
- Oncology (2084)
- Ophthalmology (596)
- Orthopedics (245)
- Otolaryngology (308)
- Pain Medicine (254)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1134)
- Primary Care Research (462)
- Public and Global Health (6593)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (345)
- Surgery (456)
- Toxicology (56)
- Transplantation (191)
- Urology (170)